尼可地尔用于老年急性心肌梗死合并糖尿病患者PCI术后的价值

doi:10.3969/j.issn.1671-7171.2022.12.017

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1143 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the application value of Nicorandil in elderly patients with acute myocardial infarction and diabetes after percutaneous coronary intervention (PCI). 【Methods】The clinical data of 98 elderly patients with acute myocardial infarction and diabetes treated by PCI were retrospectively analyzed. They were divided into the observation group (routine treatment+Nicorandil) and the control group (routine treatment) according to whether they took Nicorandil or not, with 49 cases in each group.The blood flow grades of myocardial infarction thrombolysis test (TIMI), creatine kinase isoenzyme (CK-MB) and troponin I (cTnI) before and 24 hours after operation were compared between the two groups;The left ventricular ejection fraction (LVEF), left ventricular end systolic diameter (LVESD), left ventricular end diastolic diameter (LVEDD), glycosylated hemoglobin (HbA1c), fasting blood glucose (FPG), and postprandial blood glucose (2hPG) of the two groups were also compared before and after treatment.The patients were followed up for 6 months to record the adverse cardiac events.【Results】The TIMI blood flow grading in the observation group was better than that in the control group, with a statistically significant difference (P<0.05). At 24 hours after operation, CK-MB and cTnI in the two groups were higher than those before operation, but those in the observation group were lower than those in the control group (P<0.05). LVEF after treatment was significantly higher than that before treatment, LVESD and LVEDD were significantly lower than that before treatment (P<0.05), and the difference between the observation group and the control group was statistically significant (P<0.05). After treatment, HbA1c, FPG and 2hPG in the two groups were lower than those before treatment (P<0.05), but there was no significant difference between the observation group and the control group (P>0.05). The total incidence of adverse cardiac events in the observation group was significantly lower than that in the control group (P<0.05). 【Conclusion】Nicorandil can improve microcirculation perfusion, alleviate myocardial injury, improve cardiac function and reduce adverse cardiac events in elderly patients with acute myocardial infarction and diabetes after PCI.

Key words： Nicorandil/TU Myocardial Infarction/CO Acute Disease Diabetes Mellitus/CO Percutaneous Coronary Intervention

Received: 09 March 2022

PACS:

R542.22

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Hong
	LI Hai-yan

Cite this article:

LI Hong,LI Hai-yan. Value of Nicorandil after PCI in Elderly Patients with Acute Myocardial Infarction and Diabetes[J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(12): 1819-1822.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2022.12.017 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2022/V39/I12/1819

[1] ZHOU J N,ZHONG D,WANG F,et al. Effect of glycosylated hemoglobin on heart rate variability in patients with first acute myocardial infarction in type 2 diabetes mellitus[J].J Microcir,2019,29(2):60-62.
[2] CHEN Y,DOU Z,XU W W,et al. Risk factors for symptomatic hemorrhagic transformationin and clinical outcome in severe AIS patients after thrombolytic therapy[J].Chin J Geriatr Cardiac Cereb Vasc Dis,2017,19(9):914-917.
[3] WU Y Y,CAO X Z,WANG Z Q,et al. Effect of nicorandil combined with ticagrelor on myocardial perfusion in patients with STEMI undergoing primary percutaneous coronary intervention[J].Chin J Cycle,2019,34(4):343-350.
[4] 王文丰,巨名飞,李春华,等. 老年糖尿病合并急性心肌梗死患者介入治疗后血管开通时间对心室重构和心脏功能的影响[J].中华老年心脑血管病杂志,2014,16(6):646-647.
[5] 温心,李浪. 尼可地尔治疗冠状动脉微血管疾病机制及临床应用的研究进展[J].山东医药,2019,59(32):107-110.
[6] 黄正新,王先宝,刘映峰. 尼可地尔对急性心肌梗死患者冠状动脉介入术后心功能及临床预后的影响[J].实用医学杂志,2016,32(4):544-547.
[7] NISHI T,KITAHARA H,FUJIMOTO Y,et al. Intravenous nicorandil versus adenosine for fractional flow reserve measurement:a crossover,randomized study[J].Heart Vessels,2018,33(12):1570-1575.
[8] WANG X,GENG J,ZHU H,et al. Renoprotective effect of nicorandil in patients undergoing percutaneous coronary intervention:a meta analysis of 4 randomized controlled trials[J].Oncotarget,2018,9(14):11837-11845.
[9] 韩孝宇,安建立,王文广,等. 尼可地尔对老年多支病变急性心肌梗死行急诊PCI心肌保护作用的临床研究[J].中国心血管病研究,2018,16(8):743-748.
[10] 皮淑芳,郑刚,刘迎午,等. 尼可地尔对老年急性ST段抬高型心肌梗死患者介入术后心功能的影响[J].中华老年心脑血管病杂志,2018,20(9):923-926.
[11] 樊泽元,简新闻,季汉华. 急诊PCI术中慢/无复流ST段抬高型急性心肌梗死患者术后口服尼可地尔观察[J].山东医药,2017,57(23):97-100.